Table 1 Health, economic, and social benefits of prospective Strep A vaccination and their distribution.
From: The full health, economic, and social benefits of prospective Strep A vaccination
Vaccination benefits | Individual | Family/ household | Health sector | Society | |
|---|---|---|---|---|---|
Health benefits | Direct health effects • Reduced morbidity & mortality directly due to Strep A diseases • Adverse effects of vaccination (negative benefit) | ✓ | |||
Prevention of secondary individual (physical) health effects • Aggravation of comorbidities • Nosocomial infections • Microbiome disruption | ✓ | ||||
Mitigation of secondary population-level health effects • Disease transmission • Antimicrobial resistance • Healthcare congestion | ✓ | ✓ | |||
Improved mental health | âś“ | âś“ | |||
Economic benefits | Reduced healthcare costs | âś“ | âś“ | âś“ | |
Reduced caregiving costs | âś“ | âś“ | âś“ | ||
Reduced transportation costs | âś“ | âś“ | |||
Increased labor force participation, hours worked, and income | âś“ | âś“ | âś“ | ||
Increased productive non-market activities | âś“ | âś“ | âś“ | ||
Improved educational attainment, school attendance, and cognition | âś“ | âś“ | |||
Fiscal impacts • Increased tax receipts • Reduced public health spending | ✓ | ✓ | |||
Increased wealth/savings | âś“ | âś“ | |||
Reduced risk and severity of impoverishment | âś“ | âś“ | âś“ | ||
Reduced risk of economically disruptive outbreaks | âś“ | âś“ | |||
Social benefits | Improved social equity | âś“ | |||
Intergenerational benefits | âś“ | ||||
General risk reduction | âś“ | âś“ | âś“ | âś“ | |
Improved quality of life | âś“ | âś“ | âś“ | ||
Reduced stigma | âś“ | âś“ | âś“ | âś“ |
